Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.
Goa KL, Benfield P. Goa KL, et al. Among authors: benfield p. Drugs. 1994 Mar;47(3):536-66. doi: 10.2165/00003495-199447030-00009. Drugs. 1994. PMID: 7514978 Review.
Balfour JA, Benfield P. Balfour JA, et al. Among authors: benfield p. BioDrugs. 1997 Feb;7(2):158-63. doi: 10.2165/00063030-199707020-00007. BioDrugs. 1997. PMID: 18031088
Fluoxetine. A pharmacoeconomic review of its use in depression.
Wilde MI, Benfield P. Wilde MI, et al. Among authors: benfield p. Pharmacoeconomics. 1998 May;13(5 Pt 1):543-61. doi: 10.2165/00019053-199813050-00007. Pharmacoeconomics. 1998. PMID: 10180753 Review.
Meropenem. A pharmacoeconomic review of its use in serious infections.
Holliday SM, Benfield P. Holliday SM, et al. Among authors: benfield p. Pharmacoeconomics. 1998 Mar;13(3):359-77. doi: 10.2165/00019053-199813030-00010. Pharmacoeconomics. 1998. PMID: 10178661
Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
Plosker GL, Foster RH, Benfield P. Plosker GL, et al. Among authors: benfield p. Pharmacoeconomics. 1998 Jan;13(1 Pt 1):91-106. doi: 10.2165/00019053-199813010-00009. Pharmacoeconomics. 1998. PMID: 10175990 Review.
Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
Balfour JA, Benfield P. Balfour JA, et al. Among authors: benfield p. Pharmacoeconomics. 1996 Aug;10(2):164-78. doi: 10.2165/00019053-199610020-00008. Pharmacoeconomics. 1996. PMID: 10163419 Review.
Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.
Peters DH, Benfield P. Peters DH, et al. Among authors: benfield p. Pharmacoeconomics. 1994 Oct;6(4):370-400. doi: 10.2165/00019053-199406040-00004. Pharmacoeconomics. 1994. PMID: 10147474 Review.
Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.
Whittington R, Barradell LB, Benfield P. Whittington R, et al. Among authors: benfield p. Pharmacoeconomics. 1993 Jan;3(1):45-82. doi: 10.2165/00019053-199303010-00006. Pharmacoeconomics. 1993. PMID: 10146987 Review.
Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs.
Barradell LB, Whittington R, Benfield P. Barradell LB, et al. Among authors: benfield p. Pharmacoeconomics. 1993 Feb;3(2):140-71. doi: 10.2165/00019053-199303020-00007. Pharmacoeconomics. 1993. PMID: 10146962 Review.
Orlistat.
McNeely W, Benfield P. McNeely W, et al. Among authors: benfield p. Drugs. 1998 Aug;56(2):241-9; discussion 250. doi: 10.2165/00003495-199856020-00007. Drugs. 1998. PMID: 9711448 Review.
108 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback